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Introduction
The biarylpyrazole class of cannabinoid 1 receptor (CB 1 R ) inverse agonists, which includes AM251 and rimonabant (SR141716A), has therapeutic potential as animal and clinical data suggest that they mediate suppression of appetite and improve glucose homeostasis (Padwal and Majumdar, 2007) . However, administration of rimonabant still stimulates neurogenesis and induces cannabinoid-like effects in mice deficient in cannabinoid 1 receptors (Jin et al., 2004; Wiley et al., 2012) , indicating the involvement of additional targets. Indeed, the neuroprotective effect of rimonabant requires the vanilloid receptor VR1, independent of the CB 1 R interaction (Jin et al., 2004; Pegorini et al., 2006) . These biarylpyrazole compounds also appear to have targets other than CB 1 R, CB 2 R, and VR1 (Raffa and Ward, 2012) ; for example, AM251 and rimonabant are agonists of GPR55, a recently deorphanized G-protein coupled receptor that is expressed in peripheral tissues and is positively associated with obesity in human (Moreno-Navarrete et al., 2012) . However, the effect of these compounds on the cellular functions of GPR55 requires low micromolar concentrations. For instance, AM251 induces sustained and oscillatory
Ca
2+ responses reminiscent of responses triggered by the endogenous GPR55 ligand, lysophosphatidylinositol, using a maximally effective concentration of AM251 (3 μ M), with an EC 50 of 612 ± 86 nM (Henstridge et al., 2009) . Moreover, the redistribution of (Kapur et al., 2009 ). Lastly, 1-10 µM of rimonabant and AM251 are used to demonstrate the involvement of GPR55 in cannabinoid-triggered calcium signaling in endothelial cells (Waldeck-Weiermair et al., 2008) .
Our recent study has revealed that the cellular responses to AM251 (5 µM) relied on the binding to and destabilization of estrogen-related receptor alpha (ERRα) protein (Fiori et al., 2011) . Importantly, mice lacking ERRα exhibit reduced fat mass and were resistant to diet-induced obesity (Luo et al., 2003) , a phenotype similar to that of mice lacking CB 1 R (Ravinet Trillou et al., 2004) . Members of the ERR subfamily, which encompass ERRα, ERRβ and ERRγ, are constitutively active and do not require This article has not been copyedited and formatted. The final version may differ from this version. (Ariazi and Jordan, 2006) . The orphan hormone nuclear receptor ERRα binds to promoter sites of target genes as dimers (Horard et al., 2004) . The binding of ERRα to estrogen-response element (ERE) or ERR-response element (ERRE) on specific DNA target sites leads to either transcriptional activation or repression partly depending on the presence of coregulators (Ariazi and Jordan, 2006) . A number of nuclear receptor coactivators, including the peroxisome proliferator-activated receptor γ coactivator-1 (PGC-1) α and β , interact with ERRα and potentiate its transcriptional activity (Zhang and Teng, 2000; Xie et al., 1999) . The recent report of the crystal structure of the ERRα ligand-binding domain in complex with PGC-1α has provided new evidence for ligand-independent transcriptional activation of ERRα (Kallen et al., 2004) . PGC-1α and ERRα work in concert to promote regulation of genes that control key aspects of metabolism including mitochondrial biogenesis (Schreiber et al., 2004; Eichner and Giguère, 2011) .
It is therefore possible that alterations in ERRα levels may be responsible for some of the off-target effects of AM251 that led to the upregulation of epidermal growth factor receptor expression and signaling (Fiori et al., 2011) . Here, we investigated the molecular mechanisms involved in the regulation of ERRα protein stability by AM251. Moreover, because of the important role of ERRα in the control of cellular metabolism, we also sought to determine if AM251 treatment resulted in altered mitochondrial biogenesis and function through destabilization of this orphan nuclear receptor. Our findings provide novel mechanistic insights into inducible posttranslational modifications of ERRα that subsequently augment mitochondrial mass but reduce mitochondrial bioenergetic functions.
This article has not been copyedited and formatted. The final version may differ from this version. Mini kit (Qiagen, Valencia, CA) and 1 µg RNA was reverse transcribed using qScript cDNA SuperMix (Quanta Biosciences, Gaithersburg, MD) according to the manufacturer's instructions. Gene expression was quantified and analyzed using quantitative PCR as described previously (Fiori et al., 2011 These siRNAs have been validated to perform efficient knockdown with minimal off-target effects (Fiori et al., 2011) . PANC-1 cells were reverse transcribed using Lipofectamine RNAiMAX reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Briefly, for each well of a 4-well chamber slide (Lab-Tek; Nunc, Rochester, NY), the RNAi duplex-Lipofectamine RNAiMAX complex was prepared using 0.1 nmoles of siRNA duplex and 1 μl of Lipofectamine RNAiMAX in 100 μL Opti-MEM I medium and incubated for 15 min at room temperature. PANC-1 cells (40,000 cells/well) in complete growth medium without antibiotics were then plated into chambers and incubated for 48 h prior to use. Knockdown efficiency was determined by Western blot analyses. Three independent transfection experiments were performed.
Subcellular Fractionation. Fractionation of cytoplasmic and nuclear protein extracts was carried out using NE-PER™ nuclear and cytoplasmic extraction reagents (Thermo Scientific, Rockford, IL)
supplemented with 1 mM sodium orthovanadate, protease inhibitor cocktail set I and phosphatase inhibitor cocktail set II (Calbiochem-EMB, San Diego, CA). Mitochondrial and cytosolic fractions were isolated using the mitochondria isolation kit for cultured cells (MitoSciences Inc., Eugene, OR) following the manufacturer's protocol. The cytosolic fractions were concentrated using Microcon YM-3 concentrators (Millipore-Amicon, Billerica, MA).
Immunoprecipitation. Following treatments, cells were washed twice with ice-cold PBS and snap frozen in liquid nitrogen. Cells were lysed and nuclear extracts were prepared as described above. Equal amounts of nuclear extracts were diluted in radioimmune precipitation assay (RIPA) buffer (25 mM HEPES, 134 mM NaCl, 1% NP-40, 0.1% SDS, 1 mM sodium orthovanadate, 0.5% sodium deoxycholate, 100 mM NaF) supplemented with phosphatase and protease inhibitor cocktails, and precleared with protein G agarose beads (50% v/v, Millipore DNA-binding Activity of ERRα. The protein content in PANC-1 nuclear extracts was quantified using the bicinchoninic acid assay kit (Thermo Scientific). Protein-DNA binding activity was assessed using a streptavidin-agarose pulldown assay as previously described (Wu, 2006) . Briefly, one hundred fifty µg of nuclear extracts were incubated with 1.5 μg biotinylated oligonucleotide duplex and 10 μL Statistical Analysis. Results are represented as means ± SEM unless otherwise specified. Data were analyzed using KaleidaGraph software (Version 4.1, Synergy Software, Reading, PA). Statistical analyses were performed using either a Student's t test for unpaired data or ANOVA with Fisher's LSD post-hoc test analysis. A probability level of P < 0.05 was considered statistically significant.
This article has not been copyedited and formatted. The final version may differ from this version. shown that AM251 down-regulates the expression of ERRα protein in PANC-1 cells (Fiori et al., 2011) , and an independent study has reported that the selective ERRα inverse agonist, XCT790, induces the degradation of ERRα (Lanvin et al., 2007) . We compared the effects of other compounds that are structurally related to AM251, specifically rimonabant and SLV319, in term of potency toward regulation of ERRα protein levels. A 16-h treatment of PANC-1 cells with maximal concentration (5 µM) of AM251, rimonabant, and SLV319 significantly decreased the levels of ERRα protein by ~60-70% (P < 0.001), whereas the effect was maximal (~95% reduction) with XCT790 ( Fig. 1A) . Incubation of PANC-1 cells with increasing concentrations of AM251 and related compounds produced a dose-dependent reduction in ERRα levels, with an IC 50 ranging from 0.7 -1 µM (Fig. 1B) .
Two other cell lines were also tested for their sensitivity to the biarylpyrazole compounds. While ES-2 and HepG2 cells were very responsive to XCT790, HepG2 cells showed refractoriness to the suppressive action of AM251, rimonabant and SLV319 (Supplemental Fig. 1A and B). In contrast, the sensitivity of ES-2 cells to these compounds was reminiscent of PANC-1 cells. Under these experimental conditions, the levels of ERRγ were unaffected by the biarylpyrazole compounds or XCT790 (Fig. 1A, Supplemental Fig. 1 ). These data suggest that the effect of AM251 and related analogs on the accumulation of ERRα protein is cell type-dependent.
AM251-mediated Proteasomal Degradation of ERRα. The half-life of ERRα protein was
determined by treating PANC-1 cells either with the protein synthesis inhibitor, cycloheximide (CHX, 10 µg/ml), or AM251 in a time-course experiment. Immunoblot analysis of total cell lysates showed rapid degradation rate of ERRα by CHX, with a t 1/2 of 5 h ( Fig. 2A) . However, the half-life of ERRα protein was ~10 h following AM251 treatment, suggesting confounding contributions from transcription and/or translation. Neither PGC-1 nor GAPDH protein expression was altered by these treatments. To assess This article has not been copyedited and formatted. The final version may differ from this version. whether the destabilization of ERRα in response to AM251 stemmed from proteasomal degradation, PANC-1 cells were pretreated with the proteasome inhibitor, MG132, for 1 h followed by the addition of AM251 for 6 h (Fig. 2B) . The results show complete suppression in ERRα protein degradation in MG132-treated cells, indicating that proteasome activity is likely to play a key role in the AM251-mediated destabilization of this orphan nuclear receptor.
To assess the effect of AM251 on the localization of ERRα, nuclear and cytosolic fractions were isolated and subjected to Western blot analysis. As shown in Fig. 2C , ERRα was found predominantly in the nuclear fraction, although a significant amount was detected in the extranuclear compartment as well.
Treatment with AM251 caused a decrease in ERRα levels in both subcellular fractions; however, inhibition of the proteasome complex with MG132 completely prevented the loss or redistribution of ERRα upon AM251 treatment (Fig. 2C, upper panel) . Analysis of BRG-1 and IκBα as markers of nuclear and cytosolic proteins, respectively, confirmed the absence of cross-contamination during the subcellular fractionation process (Fig. 2C, lower panel) .
DNA-binding Properties of the ERRα-containing Multiprotein Complexes. We determined if
AM251 altered the DNA-binding property of ERRα. It has been previously reported that ERRα can bind to estrogen-response elements (ERE) containing the recognition motif AGGTCAnnnTGACCT and that ERRα also recognizes the single consensus half-site sequence TNAAGGTCA, referred to as an ERRresponse element (ERRE) (Sladek et al., 1997) . Here, a DNA affinity immunoprecipitation assay was used to assess the binding of ERRα to the agarose-conjugated ERRE consensus or mutated recognition sequences. The assay combines an affinity step with Western blot analysis to detect the DNA-bound ERRα (Wu, 2006) . In the absence of MG132, the level of binding of ERRα to its target DNA was markedly reduced upon treatment of PANC-1 cells with AM251 or XCT790, as compared to control cells (Fig. 3A , lanes 4 and 6 vs. 2). In contrast, treatment with MG132 alone clearly increased the amount of DNA-bound ERRα and conferred protection against alteration in the DNA binding capacity of ERRα elicited by AM251 and XCT790 (Fig. 3A, lanes 5 and 7 vs. 3). The oligonucleotide dimer with mutated This article has not been copyedited and formatted. The final version may differ from this version. The orphan nuclear receptor ERRα interacts with a number of binding partners for full transcriptional activity. We analyzed ERRα-containing multi-protein complexes using NativePAGE gels, a technique that offers a higher resolution than gel filtration or sucrose density ultracentrifugation (Swamy et al., 2006) . Western blotting of the nuclear extract from untreated PANC-1 cells showed a stable ERRα-containing multiprotein complex of ~220 kDa, whose relative abundance increased in MG132-treated cells ( (Fig. 3C) .
Nuclear ERRα as a Putative Target for Phosphorylation-mediated SUMOylation in Response
to AM251. Because ERRα could be interacting with components of the proteasome in both the nuclear and cytosolic compartments, PANC-1 cells were pretreated with the nuclear export inhibitor, leptomycin B, alone or together with MG132, followed by subsequent incubation with AM251 or XCT790. As shown in Fig. 4A , leptomycin alone did not confer protection whereas the combination leptomycin plus MG132
prevented ERRα degradation induced by AM251 and XCT790. These results indicate that nuclear proteolytic activity may be responsible for the destabilization of ERRα.
Since proteasome inhibition results in impaired degradation of ERRα by AM251, we tested directly whether ERRα is a SUMOylation target. SUMOylation is a known posttranslational modification of ERRα (Tremblay et al, 2008) , and functions as a signal for proteasomal degradation (Miteva et al, 2010) .
This article has not been copyedited and formatted. The final version may differ from this version. were immunoblotted with ERRα antibody and gave similar results (Fig. 4B, second panel) . No signal was observed in the immunoprecipitation control with protein G beads alone.
Phosphorylation has been shown to be a requirement for ERRα SUMOylation (Tremblay et al., 2008; Vu et al., 2007) , with protein kinase Cδ being one of the potential kinases involved (Barry and Giguère, 2005) . Similar to AM251, activation of PKC with the phorbol ester PMA resulted in a significant reduction in ERRα protein levels (Fig. 4C ) in the absence of detectable alteration in ERRα mRNA expression (Fig. 4D) . Moreover, both AM251 and PMA elicited rapid and significant phosphorylation of a major PKC substrate, Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) (Fig. 4E ). These data indicate that PKC-dependent phosphorylation may be a prerequisite for AM251-mediated SUMOylation and proteolytic degradation of ERRα.
ERRα Degradation Alters the Number of Mitochondria and Mitochondrial Membrane
Potential. Through transcriptional regulation of respiratory gene expression, ERRα controls the energy generating functions of mitochondria (Eichner and Giguere, 2011) . Interestingly, AM251-treated PANC-1 cells exhibited a sharp reduction in MitoTracker Red CMXRos staining, which is dependent upon mitochondrial membrane potential (Fig. 5A ). In support of this finding, downregulation of ERRα expression by siRNA led to a marked reduction in MitoTracker Red CMXRos staining, as compared to cells transfected with control siRNA (Fig. 5B) . Consistent with the refractoriness of HepG2 cells to AM251-dependent reduction in ERRα protein levels, the mitochondrial membrane potential remained unaffected by AM251 treatment in these cells (Supplemental Fig. 2 ).
Mitotracker Green is a probe used to evaluate the mitochondrial mass and differentiate intact mitochondria from cellular debris while the measure of was associated with ERRα protein destabilization (Fig. 5C, bars) .
Mitochondrial mass is controlled through biogenesis, degradation, or both processes (Michel et al., 2012) . To further examine mitochondrial dyfunction in response to AM251, we compared the expression levels of mitochondrial proteins in the absence or presence of leupeptin and NH 4 Cl, two known lysosomal
inhibitors. Western blot analysis demonstrated that the expression of COXII and COXIII subunits, cytochrome c and VDAC/porin were unaffected in serum-depleted cells treated or not with leupeptin and NH 4 Cl for 5 h (Fig. 5D ). However, there was higher expression of VDAC/porin in AM251-treated cells when compared to vehicle controls while the level of COXII and COXIII subunits expression remained constant. Taken together, these data indicate that AM251 induces alterations to both mitochondrial mass and bioenergetics via depletion of ERRα.
We further investigated the possibility that AM251 and XCT790 negatively affected mitochondrial integrity. Treatment of PANC-1 cells with AM251 resulted in the retention of cytochrome c in the mitochondrial compartment whereas a small, but detectable amount of cytochrome c was present in the cytosolic fraction of XCT790-treated cells (Fig. 5E ). Neither AM251 nor XCT790 treatment of PANC-1 cells resulted in poly-(ADP-ribose) polymerase-1 cleavage, a process known to occur during apoptosis (Soldani and Scovassi, 2002 ) (Supplemental Fig. 3) . From these data, we conclude that the loss in ERRα protein by AM251 and related biarypyrazole compounds was not accompanied by loss in cell integrity.
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Discussion
The nuclear receptor ERRα has important modulatory roles in numerous aspects of energy metabolism, including fatty acid oxidation, glucose metabolism and mitochondrial biogenesis (Ariazi and Jordan, 2006; Villena and Kralli, 2008; Giguère 2008) . Therefore, synthetic inverse agonists targeting ERRα may be useful in the treatment of metabolic diseases as well as cancer. Recently, we have shown that AM251 promotes cellular degradation of ERRα protein (Fiori et al., 2011 ). In the current study, a variety of approaches were used to detect DNA-binding properties, native oligomeric protein complexes, and posttranslational modifications that are known mechanisms for the destabilization and proteolytic degradation of ERRα. We provide novel evidence that AM251 and related biarylpyrazole compounds induce proteasomal degradation of ERRα via posttranslational modifications, and that such degradation subsequently alters mitochondrial function.
Our previous work showed that AM251 displays affinity and specificity for the ligand-binding domain of ERRα, which translated into selective reduction in ERRα protein levels without an effect on its mRNA levels (Fiori et al., 2011) . In this study, the destabilization of ERRα by compounds structurally related to AM251 displayed a signature appropriate for this class of drugs. Interestingly, these effects appeared to be cell type-specific as AM251, rimonabant and SLV419 all promoted proteolytic degradation of ERRα in PANC-1 and ES-2 cells but not in the HepG2 cell line. Moreover, no alterations were found in protein levels of ERRγ or that of the co-activator PGC-1, regardless of cell type. However, a marked depletion in ERRα was observed in all cell lines upon exposure to the potent ERRα-specific inverse agonist XCT790. These results, which suggest a model for cell type-specific control of ERRα stability by biarylpyrazole compounds, are supported by findings in ERRα knockout mice, wherein gene induction was strongly dependent on the tissue type (Huss et al., 2004) . Alternatively, the selective reduction of ERRα levels in different cell types might fine-tune ERRα signaling, for example, to modulate osteoblastic and adipogenic programs (Ijichi et al., 2007; Delhon et al., 2009) . These This article has not been copyedited and formatted. The final version may differ from this version. In order to elucidate whether AM251-induced ERRα loss occurs through decreased protein synthesis and/or increase in proteasomal activity, specific inhibitors of each process were used. The rate of ERRα depletion by AM251 was significantly slower than that elicited by the protein synthesis inhibitor, cycloheximide, indicating that AM251 is likely to act through reduction of protein stability instead of impacting ERRα mRNA translation. Treatment with the proteasomal inhibitor MG132 abrogated AM251-induced ERRα loss, implying participation of the proteasome system. Moreover, there was accumulation of ERRα within the nucleus as a multimeric complex whose DNA binding ability was maintained in the presence of AM251, albeit to a lesser degree due to the depletion of the complex (Fig.   3 ). The lack of protection against the loss of ERRα in AM251-treated cells that were preincubated with leptomycin B (a CRM1 nuclear export inhibitor) implies that a nuclear proteasome complex is involved in ERRα destabilization by AM251 and related compounds.
Proteasomal degradation typically involves posttranslational modifications of target proteins. ERRα has been shown to undergo numerous modifications including phosphorylation (Sladek et al., 1997; Lu et al., 2011) , SUMOylation (Vu et al., 2007; Tremblay et al., 2008) , ubiquitination (Ren et al., 2011) and acetylation (Wilson et al., 2010) , many of which alter its transcriptional activity. In the current study, AM251 significantly increased SUMOylation of ERRα by SUMO-2,3 (Fig. 4B) , a posttranslational modification associated with enhanced protein turnover (Miteva et al., 2010; Manente et al., 2011; Shimshon et al., 2011) . Consistent with these findings, protein modifications with SUMO-2,3 have been associated with increased nuclear degradation (Anderson et al., 2012) . Previous mutagenesis studies have identified the critical importance of residues Lys-14 and Lys-403 for ERRα SUMOylation (Vu et al., 2007; Tremblay et al., 2008) and found this modification to also occur in vivo (Tremblay et al., 2008) .
SUMOylation has previously been linked to either the promotion (Manente et al., 2011) 
or inhibition
This article has not been copyedited and formatted. The final version may differ from this version. (Anderson et al., 2012; Sharma et al., 2010) of protein ubiquitination. Despite ERRα being a target of ubiquitination by the E3 ligase Parkin (Ren et al., 2010) , our preliminary findings failed to show any significant induction of ERRα ubiquitination by AM251 (data not shown).
Phosphorylation on Ser-19 enhances SUMOylation of ERRα on Lys-14 by SUMO2 (Vu et al., 2007; Tremblay et al., 2008) . Since PKCε is a known ERRα kinase (Lu et al., 2011) , we next sought to determine if AM251 alters PKC activity. Herein, the demonstration that phorbol ester stimulation can induce ERRα degradation paralleled the action of AM251. Similar with phorbol esters, AM251 also exhibited increased potency toward phosphorylation of an in vivo PKC substrate. This may support a role for PKC in triggering phosphorylation-dependent SUMOylation and proteasomal degradation of nuclear ERRα by biarylpyrazole compounds. Moreover, the extent of ERRα phosphorylation could also influence subsequent posttranslational modification of this nuclear receptor, thereby altering the stability of ERRα-containing protein complexes. However, no differences were observed between AM251-and vehicletreated cells in this respect ( Fig. 3B and C) . Nuclear extracts were resolved by NativePAGE gel electrophoresis and a single 220-kDa complex was detected in both experimental conditions. In addition, the free monomeric form of ERRα did not exist, and no changes in these parameters were observed upon cell treatment. Although ERRγ, PGC-1 and RIP140 have been found to interact with ERRα, our data indicate that they are not integral members of the endogenous, nuclear ERRα-containing complex. In support of our findings, SUMOylation has no effect on either DNA-binding properties or coactivator recruitment to ERRα (Tremblay et al., 2008) . A major effort is currently underway in our laboratory to identify the components of the 220-kDa complex.
Given the critical importance of ERRα in regulating expression of numerous mitochondrial genes (Eichner and Giguère, 2011) , we hypothesized that AM251 would subsequently alter mitochondrial function through downregulation of this orphan nuclear receptor. Recent findings have indicated that treatment with the AM251 analog, rimonabant, increased hepatic mitochondrial respiration in rats fed a high-fat diet (Flamment et al., 2009 ). However, no differences were observed in the quantity of This article has not been copyedited and formatted. The final version may differ from this version. mitochondrial DNA and the citrate synthase activity. The increase in mitochondrial activity would be expected to increase energy supply, but there was a reduction in ATP synthase activity, consistent with an increase in mitochondrial proton leak (Flamment et al., 2009) . Here, we found that treatment with AM251 or siRNA-mediated ERRα silencing exerted negative effects on mitochondrial staining with Mitotracker
Red CMXRos. Different hypotheses may explain changes in mitochondrial function: 1) both approaches may interfere with mitochondrial electron transport; 2) mitochondrial activity may be impaired via depletion of NADH; or 3) the mitochondrial permeability transition pore complex may be compromised.
It should also be noted that TMRM and mitotracker green assays were also performed and indicated a clear mitochondrial dysfunction in response to AM251 or XCT790 despite increased mitochondrial biogenesis. Moreover, our previous report found that AM251 decreased mRNA level of an important mitochondrial gene, PDK4 (Fiori et al., 2011) . Our observations, together with a recent investigation by
Michel and colleagues (Michel et al., 2012) , provide examples of a putative retrograde response that enables cells to adapt to impaired mitochondrial activity.
In summary, we have demonstrated that the biarylpyrazole class of compounds reduces ERRα protein stability in association with altered mitochondrial dysfunction. We propose a molecular mechanism that contributes to ERRα degradation via increased PKC activity leading to SUMOylation and subsequent nuclear proteasomal degradation, which, in turn, leads to alterations in genes critical to mitochondrial biogenesis and function. The impairment of metabolic function for ERRα combined with recent reports of the significant effects of AM251 and rimonabant on GPR55, GABA receptors, and µ-opioid receptors (Sharir and Abood, 2010; Baur et al., 2012; Seely eta al., 2012) , are suggestive of drugs that in fact display significant off-target effects. Therefore, the findings demonstrated herein may aid in the optimization of future therapeutics aimed at treating metabolic diseases with minimal side effects.
This article has not been copyedited and formatted. The final version may differ from this version. Similar results were obtained in a separate experiment.
